Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Director bought 900 shares at $3.31 ($2,979)
  2. 4 Open-market buy Director bought 500 shares at $3.60 ($1,800)
  3. 4 Open-market buy Director bought 2,000 shares at an average $3.36 ($6,710)
  4. 4 Open-market sale V.P., Finance & CFO sold 2,000 shares at an average $3.26 ($6,525)
  5. 4 Open-market buy Director bought 2,604 shares at an average $3.31 ($8,630)
  6. 4 Open-market buy Director bought 500 shares at an average $2.88 ($1,438)
  7. 4 Open-market buy Director bought 200 shares at $2.82 ($564)
  8. 4 Open-market buy Director bought 600 shares at an average $3.01 ($1,807)
  9. 4 Open-market buy Director bought 100 shares at $3.03 ($303)
  10. 4 Open-market buy Director bought 720 shares at $2.76 ($1,985)
  11. 4 Open-market buy Director bought 500 shares at $2.85 ($1,425)
  12. 4 Open-market buy Director bought 500 shares at $2.96 ($1,480)
  13. 4 Open-market buy Director bought 500 shares at $2.94 ($1,470)
  14. 4 Open-market buy Director bought 500 shares at $3.31 ($1,655)
  15. 4 Open-market buy Director bought 2,000 shares at $2.29 ($4,580)
  16. 4 Open-market buy Director bought 2,000 shares at an average $2.46 ($4,920)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 24 · 471 filings